Engflag

Reumetan

Quick links to important sections

Reumetan

Reumetan_EN

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Reumetan

Property Description
Active Ingredient Piroxicam beta-Cyclodextrin complex
Form Oral dosage forms (e.g., Tablets or Capsules)
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
General Purpose Relief from pain and inflammation
Origin Synthetic compound (Piroxicam)

What Type of Medicine is Reumetan?

Reumetan is a systemic pharmaceutical preparation classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). Its core identity is defined by the synthetic active ingredient, Piroxicam, which belongs to the oxicam class of NSAIDs, a grouping recognized for its sustained duration of pharmacological activity.

The preparation is administered via the oral route for systemic action throughout the body. The general purpose of this classification is to address underlying inflammatory processes and general discomfort. These agents are fundamental in managing the symptomatic manifestations of inflammation. This confirms that the medicine works to reduce the body's inflammatory response. Reumetan is generally used by adult patients requiring effective systemic management of musculoskeletal pain.

Composition: The Piroxicam beta-Cyclodextrin Complex

The defining pharmaceutical composition of Reumetan involves the Piroxicam beta-Cyclodextrin complex. The active component, Piroxicam, is purposefully bound to beta-Cyclodextrin, a specialized excipient derived from a natural carbohydrate source.

This complex formulation is engineered to enhance the drug's properties. By complexing the active substance, beta-Cyclodextrin significantly increases its solubility, leading to an enhanced pharmacokinetic profile compared to traditional Piroxicam. The specialized formulation allows the active substance to be absorbed more quickly into the system. This structure achieves a quicker and more efficient rate of absorption from the gastrointestinal tract, distinguishing it from standard Piroxicam delivery systems.

What is the General Purpose of Reumetan?

The general purpose of Reumetan is to provide symptomatic relief by intervening in the physiological process of inflammation. As an NSAID, the medication works by inhibiting the synthesis of prostaglandins, which are key molecules that regulate the experience of pain and initiate the inflammatory response. The therapeutic aim is the simultaneous reduction of pain and swelling. The unique formulation supports this purpose by facilitating a relatively rapid onset of action, ensuring the systemic anti-inflammatory effects become available to manage acute inflammatory symptoms more efficiently.

Regulatory References

  1. NIH StatPearls

What side effects are possible with Reumetan?

Possible Side Effects and Safety Information

The safety profile of Reumetan, containing the NSAID Piroxicam, is defined by mandated warnings and adverse reaction classifications documented in authoritative government regulatory sources.

Classification of Adverse Reactions

Adverse reactions are classified based on their frequency and the physiological System-Organ Class (SOC) affected. The most Common adverse reactions often involve the Gastrointestinal System, including symptoms such as dyspepsia (indigestion), abdominal pain, and nausea. Effects on the Nervous System, like headache and dizziness, are also commonly documented. Less frequent, or Rare, effects include severe changes to the Hepatobiliary or Renal and Urinary Systems, which underscore the drug’s systemic action.

Documented Serious Adverse Reactions

Official labeling explicitly highlights several risks that are considered serious adverse reactions associated with the use of Piroxicam:

  • Gastrointestinal Risk: The risk of developing peptic ulceration, gastrointestinal bleeding, and perforation is a major documented safety concern. This severe risk can occur at any point during treatment, often without prior warning symptoms.
  • Cardiovascular and Thrombotic Risk: The medication is associated with an increased potential for serious thrombotic events, including myocardial infarction (heart attack) and stroke, which may increase with the duration of use.
  • Severe Skin Reactions: Rarely, use has been associated with severe cutaneous adverse reactions (SCARs), including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Population-Specific Safety Considerations

Certain patient populations are identified in regulatory documentation as having an elevated safety risk. Older adults (geriatric patients) are explicitly documented to be at a significantly increased risk for serious gastrointestinal events. Furthermore, the medicine is contraindicated in patients with severe pre-existing conditions such as severe heart failure, severe hepatic impairment, or severe renal impairment, due to heightened risk of toxicity.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information regarding Reumetan (Piroxicam beta-Cyclodextrin complex) overdose specifies the potential for severe and life-threatening outcomes. Overdose manifestations documented in regulatory sources for Piroxicam, a Nonsteroidal Anti-Inflammatory Drug (NSAID), include gastrointestinal effects such as nausea, vomiting, stomach pain, and signs of internal bleeding like bloody or tarry stools. Central Nervous System (CNS) effects may involve severe headache, drowsiness, confusion, agitation, and, in severe cases, convulsions or decreased level of consciousness (coma).

The most serious complications officially documented are gastrointestinal bleeding, ulceration, and perforation, along with acute renal decompensation (little to no urine production) and shock (low blood pressure). These severe outcomes emphasize the mandatory requirement to seek emergency medical attention immediately for any suspected overdose, particularly if the person has collapsed, is seizing, or has difficulty breathing.

Treatment is strictly symptomatic and supportive, as no specific antidote is known for Piroxicam overdose. Management procedures described in official labeling include monitoring vital signs and laboratory parameters, and may involve the use of activated charcoal or gastric lavage. Population-specific notes indicate an increased risk of serious GI events in elderly patients and heightened susceptibility in individuals with pre-existing kidney or liver impairment.

Therapeutic Uses of Reumetan

What Reumetan Treats: Main Uses and Benefits

Reumetan is considered relevant for providing symptomatic support for adults dealing with conditions where symptoms relate to inflammatory or irritative states. The medication is indicated for relief of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA). It helps ease the persistent cluster of symptoms that includes joint pain, stiffness, and swelling, which are symptoms that interfere with daily functioning. This use contributes to improved day-to-day comfort during periods of heightened symptoms.

The medication is commonly used across conditions presenting with acute episodes, such as flares of acute gout, and is applied in situations involving recurrent or episodic manifestations like primary dysmenorrhoea (menstrual pain). It also provides supportive relief for musculoskeletal trauma and postoperative discomfort.

“It provides supportive relief to moderate these distressing manifestations, contributing to improved comfort during difficult episodes.”

This application is relevant in clinical settings that involve acute or unstable symptom patterns, may assist with maintaining functional stability when symptoms interfere with routine activities.

Quick Fact: Symptomatic Support for Inflammatory Processes
The Piroxicam beta-Cyclodextrin complex is used in addressing symptoms related to physical discomfort and noticeable physiological strain stemming from inflammatory processes.

Eligibility and Restrictions for Use

Reumetan is intended for use by adult patients for inflammatory conditions, provided they meet specific health criteria outlined in official regulatory documents. Use is strictly defined by the presence or absence of certain high-risk conditions and physiological states.

Absolute Contraindications

Use is prohibited for patients with a known hypersensitivity to piroxicam or a history of severe allergic-type reactions (e.g., asthma, urticaria) after taking aspirin or other NSAIDs. The medicine must not be used if a patient has active gastrointestinal ulceration, bleeding, or perforation, or a diagnosis of severe heart failure. It is also contraindicated for the management of peri-operative pain following Coronary Artery Bypass Graft (CABG) surgery.

Population and Organ Function Restrictions

Category Eligibility Status (Regulatory Wording)
Pregnancy Contraindicated during the third trimester (after 30 weeks gestation).
Lactation Not recommended during breastfeeding or for women attempting conception.
Age Use is not established in the pediatric population; administration to patients over 80 years old should be avoided.
Organ Function Contraindicated in cases of severe hepatic impairment or severe renal impairment.

What should I know about interactions with other medicines?

Reumetan Interactions with other medicines and products

This section describes interactions for Reumetan (Piroxicam) as formally documented in government regulatory sources.

Classification Constraint or Interaction Pattern
Formal Contraindication Use is prohibited for managing peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) Surgery.
Avoid Combination Co-administration with other systemic NSAIDs or Aspirin (at analgesic doses) is not recommended due to the significantly increased risk of serious gastrointestinal events.

Pharmacodynamic and Exposure-Modifying Interactions

Reumetan's interaction profile is characterized by effects on hemostasis, renal clearance, and therapeutic efficacy of co-administered agents:

  • Bleeding Risk Reinforcement: Concomitant use with drugs that interfere with hemostasis, such as anticoagulants (e.g., Warfarin), antiplatelet agents, and SSRIs/SNRIs, results in a documented increased risk of serious bleeding.
  • Reduced Therapeutic Effect: The medication may diminish the antihypertensive effects of ACE Inhibitors, ARBs, and Beta-Blockers, and reduce the natriuretic effect of Diuretics.
  • Exposure Elevation: Piroxicam has been reported to increase the serum concentrations of co-administered medicines, including Lithium, Methotrexate, and Digoxin, due to reduced renal clearance of these substances.

Population and Administration Notes

  • Metabolic Pathway: Piroxicam is primarily metabolized via CYP2C9. Patients known to be poor CYP2C9 metabolizers are documented to have abnormally high plasma levels due to reduced metabolic clearance.
  • High-Risk Populations: The risk of deterioration of renal function when combining Piroxicam with ACE Inhibitors/ARBs is specifically noted as being higher in elderly, volume-depleted, or renally impaired patients.
  • Food Interaction: For the Piroxicam beta-Cyclodextrin complex, ingestion with food delays the rate of absorption but does not alter the overall bioavailability of the drug.

Mechanism of Action

The mechanism of action for Reumetan is defined by its ability to modulate key chemical signaling pathways. The active substance engages its biological targets, resulting in downstream physiological consequences.

Enzyme Inhibition and the Prostanoid Pathway

The fundamental mechanism is the reversible, non-selective inhibition of the Cyclooxygenase ( COX-1 and COX-2) enzymes. This action blocks the initial step in the arachidonic acid cascade, preventing the synthesis of powerful signaling molecules known as prostanoids, notably Prostaglandin E2 ( PGE2). This molecular modification modulates the intensity of prostanoid-mediated signaling.

Modulation of Nociceptive Signaling

By reducing the local concentration of PGE2 in tissues, the drug's mechanism functionally modulates the sensitivity of peripheral sensory nerve endings (nociceptors). PGE2 typically lowers the activation threshold of these nerves, amplifying signal transmission; by limiting its production, the drug influences the signaling threshold within these neural pathways. This action decreases the contribution of excessive chemical mediator activity on the nervous system.

The Solubility-Accelerating beta-Cyclodextrin Mechanism

A key component is the Piroxicam-beta-Cyclodextrin complex, which functions as a solubility-accelerating mechanism by significantly increasing the dissolution rate of the active substance. This specialized formulation mechanism ensures the core COX inhibitory action is initiated and becomes functionally available to modulate pathways more quickly, which enables the core inhibitory action to engage more rapidly.

Dosage and Administration Information

Administration Guidelines for Methotrexate (Reumetan)

The following guidelines pertain to non-oncological use, such as for Rheumatoid Arthritis and Psoriasis.

Administration Scope Details
Route of Administration Oral (tablet or solution), Subcutaneous (SC), Intramuscular (IM), or Intravenous (IV).
Dosing Schedule Must be taken once weekly. Daily administration of the recommended weekly dose is prohibited and can be fatal.
Typical Adult Dosing Range Initial doses start at approximately 7.5 mg once weekly. The dose may be adjusted to achieve optimal response, but typically should not exceed 20 mg to 25 mg once weekly for these conditions.
Pediatric Dosing Rule Dosing for conditions such as Juvenile Idiopathic Arthritis (JIA) is typically calculated based on body surface area (e.g., 10 mg/m^2) once weekly.
Timing in Relation to Meals Oral tablets may generally be taken with or without food.
Missed-Dose Rule If a dose is missed, the patient must contact their healthcare provider immediately for instruction. Do not take a double dose or the missed dose on a different day without explicit medical direction.

Official Procedural Steps

  • Dose and Day Verification: Confirm the correct dose and the specific day of the week designated for the single weekly administration.
  • Oral Administration: Tablets should be swallowed whole.
  • Injection Administration: For SC, IM, or IV administration, use strict aseptic technique. Patients trained for self-injection must rotate injection sites to minimize local reactions.
  • Disposal: All used needles and syringes/pens must be disposed of immediately in a designated sharps container.

The structure of the drug's use is defined by the strict once-weekly frequency, which must be adhered to regardless of the chosen administration route (oral or injection). The starting dose is gradually adjusted according to individual response, but the maximum weekly dose should generally not be exceeded.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Reumetan

Evidence for Chronic Inflammatory Joint Conditions

Research examined outcomes related to physical discomfort in individuals with long-standing conditions like Osteoarthritis (OA) and Rheumatoid Arthritis (RA). The evidence base includes Randomized Controlled Trials (RCTs) and systematic reviews that studied symptom intensity and functional ability. Trials reported patterns of symptom measurements for Reumetan that were observed in studies to align with those for standard Piroxicam over typical treatment periods. While Reumetan was evaluated in settings involving chronic disease, there is limited information for long-term outcomes specifically for the beta-Cyclodextrin complex formulation. The majority of research supporting long-term use belongs to aggregated data from the parent compound.

Evidence for Rapid Relief in Acute Pain States

Specific research explored short-term symptom patterns during acute episodes, such as postoperative discomfort, using pharmacokinetic (PK) studies and comparative single-dose trials. These studies focused on measuring the time it took for the active substance to be absorbed and the onset of perceived discomfort. The PK studies reported that the specialized complex achieved peak concentrations in the bloodstream at an earlier time point compared to standard Piroxicam, reflecting a difference in the rate of absorption. However, research has not fully established the clinical implication of the quicker absorption rate when studies explored conditions requiring sustained, chronic relief. Furthermore, comparative evidence is lacking regarding whether the earlier onset was associated with long-term outcomes related to functional recovery.

Evidence Gaps and Uncertainty

Research examined conditions such as chronic low back pain in specific trials, measuring reported pain levels and functional disability scores. The evidence for this particular localized indication has been described as sparse, and evidence quality varies across studies. A general limitation across the entire evidence base is that follow-up durations were limited in many trials using the Reumetan formulation, resulting in limited information for long-term outcomes. Additionally, data for certain groups remain insufficient, including individuals at the extremes of the adult age range or those with specific co-morbidities.

Key Studies & References

  1. Nonsteroidal Anti-inflammatory Drugs (NSAIDs) - NIH StatPearls

Frequently Asked Questions (FAQ)

Common questions about Reumetan (FAQ)

Q: What is Reumetan, and what is it used for?

A: Reumetan is the brand name for the drug methotrexate. It belongs to a class of medicines called antimetabolites and acts as a disease-modifying antirheumatic drug (DMARD). It works by interfering with the growth of certain cells in the body and by suppressing the immune system.

Reumetan is used to treat several conditions:

  • Rheumatoid arthritis (RA): It is a first-line treatment, often used in adults and some children, to reduce pain, swelling, and joint damage.
  • Psoriasis: It is used to treat severe, disabling psoriasis that hasn't responded well to other treatments.
  • Certain types of cancer: It is used alone or with other medicines to treat various cancers, including breast cancer, lung cancer, and leukemias.

Q: How should I take Reumetan?

A: Reumetan is available in tablet and injectable forms. The way you take it depends on the condition being treated.

  • For Rheumatoid Arthritis and Psoriasis: Reumetan is typically taken once weekly. It is essential to choose one specific day of the week to take your dose.
  • For Cancer: Dosing schedules are highly variable and are determined by your doctor based on the specific type of cancer and your treatment plan. This may involve taking it daily, weekly, or in cycles.

Important: Due to the risk of serious harm, it is crucial to follow your doctor's exact instructions regarding the dose and frequency. Never take Reumetan every day when it is prescribed as a once-weekly dose.

Q: What are the common side effects of Reumetan?

A: The most common side effects associated with Reumetan are usually mild and may include:

  • Nausea and vomiting
  • Stomach pain or discomfort
  • Diarrhea
  • Loss of appetite
  • Headache
  • Dizziness or feeling tired
  • Temporary hair thinning

These side effects are often less severe when Reumetan is taken with folic acid (a form of vitamin B), which your doctor will likely prescribe to help reduce certain side effects.

Q: Why is folic acid prescribed with Reumetan?

A: Reumetan works by interfering with the body's use of folic acid. While this action helps treat certain diseases, it can also lead to side effects like mouth sores, stomach upset, and liver enzyme elevation.

Your doctor will typically prescribe a folic acid supplement to be taken on days when you do not take Reumetan. This helps to reduce or prevent many of the common side effects of Reumetan without reducing its beneficial effects in treating conditions like rheumatoid arthritis or psoriasis.

Q: Can I drink alcohol while taking Reumetan?

A: You should avoid or strictly limit alcohol consumption while taking Reumetan. Both Reumetan and alcohol can potentially cause or worsen liver damage. Combining the two significantly increases the risk of serious liver problems.

Discuss your alcohol use with your doctor, as they may advise complete avoidance, particularly if you have pre-existing liver issues or are on long-term Reumetan therapy.

Q: What should I do if I miss a dose of Reumetan?

A: Since Reumetan dosing is critical, especially for weekly regimens, it's important to know what to do if a dose is missed.

  • If you remember within one or two days of your scheduled weekly dose: Contact your healthcare provider immediately for instructions. They may advise you to take the dose or wait until your next scheduled day.
  • Do not take an extra dose or try to double up to make up for the missed one.

Always consult your healthcare provider before taking any action, as instructions can vary based on your specific condition and treatment plan.

Q: Are there any important drug interactions I should know about?

A: Yes, Reumetan can interact with several other medications, which can increase the risk of side effects or change how Reumetan works. Key interactions include:

  • Certain antibiotics (such as trimethoprim/sulfamethoxazole)
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen or naproxen (may require careful monitoring or dose adjustments)
  • Proton pump inhibitors (PPIs) for acid reflux (e.g., omeprazole)

It is essential to provide your doctor and pharmacist with a complete list of all prescription drugs, over-the-counter medications, and herbal supplements you are taking to check for potential interactions.

Q: Can Reumetan affect fertility or pregnancy?

A: Yes, Reumetan can pose serious risks during pregnancy.

  • Pregnancy: It can cause severe birth defects, miscarriage, or fetal death. Women who are pregnant or planning to become pregnant should not take Reumetan.
  • Contraception: Women of childbearing potential must use effective contraception during treatment and for a specific period after the last dose (usually at least one ovulatory cycle).
  • Men: Men must also use effective contraception while taking Reumetan and for a specific period after the last dose (usually at least three months).

If you are a man or woman taking Reumetan and pregnancy is a possibility, discuss the necessity of contraception with your healthcare provider. You should also tell your doctor immediately if you become pregnant while on the medication.

How should Reumetan be stored and disposed of?

How to Store and Dispose of Reumetan

Official regulatory documents define strict conditions for the storage and disposal of Reumetan (Piroxicam beta-Cyclodextrin complex).

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, 20 °C to 25 °C (68 °F to 77 °F).
Protection Must be protected from light and moisture.
Container Keep in the original, tightly closed container.

All medication must be stored out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Unused or expired product must be disposed of according to local regulations. Utilize a drug take-back program where available.

Do not dispose of Reumetan via wastewater (e.g., flushing down the toilet) to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Reumetan found in:

A-Z Index: